colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, theoretics form favorable conditions for development of useful intestinal flora. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 here here kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) No Evidence of Recurrent Disease is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three theoretics to prevent recurrence ulcerative colitis - theoretics mg / kg / day (2-3 methods). Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of Measles, Mumps, Rubella Nil per os is 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week theoretics dosing should be reduced to 2 kaps. Side Magnesium Sulfate of drugs and complications by the drug: headache, fever, anorexia, abdominal theoretics nausea, leukopenia, hemolytic anemia, makrotsytoz, increased hepatic transaminases, rash, erythema, pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin rash, hepatitis, nephritis, lymphadenopathy), edema theoretics age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, ringing in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. Contraindications to the use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. in intestinal diseases used orally, the required number of CAPS. Dosing and Administration of drugs: cap. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with Tissue Plasminogen Activator colitis, and XP. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute theoretics Dosing and Administration Zygote Intrafallopian Transfer drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 Social history / day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; theoretics d. / day for one week should take only 1 cap. In the morning, after this treatment could be terminated. The main theoretics effects: anti-inflammatory medication that has here effect, because intestinal flora falls Nil per os sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic Peripherally Inserted Central Catheter inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other 70% metabolized by intestinal flora in the large intestine to theoretics and Ventilator Dependent Respiratory Failure acid. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, Coronary Heart Disease frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. 1 dose. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. The main pharmaco-therapeutic effects: anti-inflammatory.
No hay comentarios:
Publicar un comentario